Skip to content

Dexmedetomidine for Laryngeal Mask Airway Insertion

Optimal Dose of Dexmedetomidine for Laryngeal Mask Airway Insertion During Propofol Induction

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01852539
Enrollment
22
Registered
2013-05-13
Start date
2013-07-31
Completion date
2013-08-31
Last updated
2014-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Usage

Keywords

LMA insertion, dexmedetomidine, propofol

Brief summary

The investigators attempted to determine the optimal dose of dexmedetomidine required for the successful insertion of LMA during propofol induction without a neuromuscular blocking agent.

Detailed description

After a predetermined bolus dose of dexmedetomidine was injected over 2 min, anesthesia was induced with propofol 2.0 mg/kg. After confirming the loss of eyelash reflex and the bispectral index (BIS) score decreased below 60, the insertion of LMA was attempted.

Interventions

DRUGdexmedetomidine

The dose of dexmedetomidine was determined by modified Dixon's up-and-down method, starting from 0.5 μg/kg (0.1 μg/kg as a step size).

DRUGpropofol

Propofol 2.0 mg/kg was administrated

The insertion of laryngeal mask airway (LMA) was attempted, after confirming the loss of eyelash reflex,the bispectral index (BIS) score decreased below 60.

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II patients undergoing general anesthesia for short elective surgery (\<1 hr)

Exclusion criteria

* G-E reflux * obesity (BMI\>30) * anticipated difficult airway

Design outcomes

Primary

MeasureTime frameDescription
successful insertion of LMAfrom baseline to 2 min after insertion of LMA (participants will be followed for the duration of anesthetic induction, an expected average of 10 min).the response of patients to the insertion of LMA (classified as either 'movement' or 'no movement') during infusion of dexmedetomidine and propofol.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026